Bausch Health Companies Inc (NYSE:BHC)
$ 6.88 -0.07 (-1.01%) Market Cap: 2.53 Bil Enterprise Value: 23.87 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 73/100

Bausch Health Companies Inc at Morgan Stanley Healthcare Conference Transcript

Sep 10, 2019 / 02:35PM GMT
Release Date Price: $22.49 (+1.81%)
David Reed Risinger
Morgan Stanley, Research Division - MD in Equity Research and United States Pharmaceuticals Analyst

Let's get started here. So thanks, everyone, for joining us for this session with Bausch Health. It's very much my pleasure to welcome Paul Herendeen, who was the company's CFO. And I just need to refer you to disclaimers at www.morganstanley.com/researchdisclosures.

And I thought that it makes sense to ask Paul to offer some brief opening remarks about the company's transformation, and then we'll go into Q&A.

So Paul, thank you again for being here.

Paul S. Herendeen
Bausch Health Companies Inc. - Executive VP & CFO

Yes, thanks, David. And it's great to be here. I'll give you a friendly opening remarks by saying, when Joe joined in the beginning of '16, and then I joined in the summer of '16, this was the first conference that I came to in 2016 as then the CFO of Valeant. And I just can't tell you how different it is sitting

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot